Newsroom
Saniona Icon blue
Latest News
May 25, 2022
PRESS RELEASE May 25 , 202 2 Today, on May 25 , 2022, the annual shareholders’ meeting was held in Saniona AB . T he annual shareholders’ meeting was held only by advance voting (postal vote) in accordance with temporary legislation . A summary of the adopted resolutions follows below.
May 25, 2022
  Q1 2022 ( Q1 2021 ) Revenue was SEK 6.6 M (3.4 M) Operating loss was SEK -133.2 M (-94.1 M) Net loss was SEK -133.4 M (-83.4 M) Loss per share was SEK -2.14 (-1.34) Diluted loss per share was SEK -2.14 (-1.34) Business highlights in Q1 2022 Saniona initiated the Multiple Ascending Dose (MAD)
May 23, 2022
PRESS RELEASE May 23 , 202 2 Saniona (OMX: SANION), a clinical - stage biopharmaceutical company focused on rare diseases, today announced that the results from the randomized controlled clinical trial of Tesomet for weigh t loss in patients with hypothalamic obesity has been published in the
If you have any questions regarding Saniona's media communication, feel free to contact us at any time.
thomas feldthus
Thomas Feldthus, co-founder and CEO Email: investor@saniona.com